Immunohistochemical evaluation of AKT protein activation in canine mast cell tumours

about

Gain-of-function mutation in PTPN11 in histiocytic sarcomas of Bernese Mountain Dogs.

P2860

Q47955988-7D3266F6-0EB5-4EE4-9032-B9CE61B29465

P2860

Immunohistochemical evaluation of AKT protein activation in canine mast cell tumours

Item

http://www.wikidata.org/entity/Q35926007

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Immunohistochemical evaluation of AKT protein activation in canine mast cell tumours

@ast

Immunohistochemical evaluation of AKT protein activation in canine mast cell tumours

@en

type

Item

label

Immunohistochemical evaluation of AKT protein activation in canine mast cell tumours

@ast

Immunohistochemical evaluation of AKT protein activation in canine mast cell tumours

@en

prefLabel

Immunohistochemical evaluation of AKT protein activation in canine mast cell tumours

@ast

Immunohistochemical evaluation of AKT protein activation in canine mast cell tumours

@en

P1476

Immunohistochemical evaluation of AKT protein activation in canine mast cell tumours

@en

P2093

B Tameru

http://www.w3.org/2001/XMLSchema#string

C D Fermin

http://www.w3.org/2001/XMLSchema#string

K Fadlalla

http://www.w3.org/2001/XMLSchema#string

S Rodriguez

http://www.w3.org/2001/XMLSchema#string

T Graham

http://www.w3.org/2001/XMLSchema#string

T Samuel

http://www.w3.org/2001/XMLSchema#string

P2860

Hallmarks of Cancer: The Next Generation

Kit signaling through PI 3-kinase and Src kinase pathways: an essential role for Rac1 and JNK activation in mast cell proliferation

Regulation of hematopoietic stem cells by the steel factor/KIT signaling pathway

The phosphatidylinositol 3-Kinase AKT pathway in human cancer

Targeting PI3K signalling in cancer: opportunities, challenges and limitations

Evaluation of the kinase domain of c-KIT in canine cutaneous mast cell tumors.

Mast cell tumors in the dog.

The biology of Kit in disease and the application of pharmacogenetics.

The RAS/RAF/MEK/ERK and PI3K/AKT signaling pathways present molecular targets for the effective treatment of advanced melanoma.

Pharmacological targeting of the KIT growth factor receptor: a therapeutic consideration for mast cell disorders.

P304

171-176

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JCPA.2011.12.003

http://www.w3.org/2001/XMLSchema#string

P433

2-3

http://www.w3.org/2001/XMLSchema#string

P478

147

http://www.w3.org/2001/XMLSchema#string

P577

2012-01-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221790758

http://www.w3.org/2001/XMLSchema#string

P698

22289273

http://www.w3.org/2001/XMLSchema#string

P921

mast cells

immunohistochemistry

P932

3341505

http://www.w3.org/2001/XMLSchema#string

Immunohistochemical evaluation of AKT protein activation in canine mast cell tumours

about

P2860

P2860

Immunohistochemical evaluation of AKT protein activation in canine mast cell tumours

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932